Nicholas Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-30,510
Closed -$7.21M 238
2020
Q4
$7.21M Buy
30,510
+50
+0.2% +$11.5K 0.14% 176
2020
Q3
$8.29M Buy
30,460
+30
+0.1% +$8.28K 0.17% 134
2020
Q2
$8.83M Sell
30,430
-4,545
-13% -$1.23M 0.2% 122
2020
Q1
$8.32M Sell
34,975
-115
-0.3% -$26.4K 0.24% 107
2019
Q4
$7.68M Sell
35,090
-50
-0.1% -$10.1K 0.16% 142
2019
Q3
$5.95M Hold
35,140
0.13% 166
2019
Q2
$6.44M Sell
35,140
-90
-0.3% -$15.7K 0.14% 155
2019
Q1
$6.48M Hold
35,230
0.15% 152
2018
Q4
$5.84M Hold
35,230
0.15% 155
2018
Q3
$6.79M Buy
35,230
+5,130
+17% +$913K 0.15% 154
2018
Q2
$5.12M Buy
30,100
+2,910
+11% +$451K 0.12% 187
2018
Q1
$4.43M Buy
+27,190
New +$4.44M 0.1% 188
2017
Q1
Sell
-71,865
Closed -$5.29M 222
2016
Q4
$5.29M Buy
71,865
+35
+0% +$2.85K 0.12% 143
2016
Q3
$6.26M Sell
71,830
-85
-0.1% -$8.03K 0.14% 120
2016
Q2
$6.19M Hold
71,915
0.12% 114
2016
Q1
$5.72M Buy
71,915
+27,880
+63% +$2.52M 0.12% 115
2015
Q4
$5.54M Buy
44,035
+2,000
+5% +$241K 0.1% 123
2015
Q3
$4.38M Buy
42,035
+3,000
+8% +$385K 0.08% 138
2015
Q2
$4.82M Buy
39,035
+14,515
+59% +$1.83M 0.08% 140
2015
Q1
$2.89M Buy
+24,520
New +$2.94M 0.05% 196

Other funds holding VRTX